Our HIPEC center is one of the busiest and most experienced in the world. We perform more HIPEC surgeries than any center in the western United States. Because of our experience, our outcomes are among the very best, and we are constantly working to improve them.
Facts and figures
- Number of HIPEC surgeries performed: Approximately 750 between August 2007 and December 2021
- 61% for appendix cancer
- 21% for colorectal cancer
- 8% for mesothelioma
- 9% for other cancers
- Median estimated blood loss (EBL): 200cc
- Patients’ median peritoneal cancer index (PCI): 13
- Median length of stay (LOS) in hospital: 9 days
Rate of complications
Mortality (within 60 days of surgery)
| 0.6% | 2.3% |
Any complication (within 60 days of surgery)
| 60.5% | 53.8% |
Serious complication (within 60 days of surgery)
| 2.5% | 24.8% |
| Return to OR | 2.7% | 10.9% |
| Bowel leak | 2.1% | 7.9% |
| Abscess | 4.1% | 7.2% |
| Wound infection | 4.9% | 6.8% |
| Blood clot | 2.4% | 5.2% |
| Ileus (delayed gastric function of more than 7 days) | 12.1% | 5.1%* |
| Readmission (within 60 days of surgery) | 15.7% | 22.6% |
* Published outcomes use alternate definition of ileus.
Notes: Data for UC San Diego Health is from August 2007 to December 2021.
Reference for average published outcomes: J Clin Oncol 2012;30(20):2449-56;
- German: Ann Surg Oncol. 2019;26(1):148-154
- Wake Forest: J Am Coll Surg. 2014;218(4):573-85
- UK1: Eur J Surg Oncol. 2016;42(7):1035-41
- UK2: Eur J Surg Oncol. 2015;41(3):396-9
- Dutch: Ann Surg Oncol. 2013;20(13):4224-30
- French: J Surg Oncol. 2016;113(7):796-803
- NSQIP: JAMA Netw Open. 2019;2(1):e186847
- NSQIP Reasmission: J Surg Res. 2019;234:103-109
- Israeli: J Surg Oncol. 2017;116(7):914-920
- Umass: Ann Surg Oncol. 2019;26(2):490-49